← Back to Search

Other

PH94B for Social Anxiety Disorder

Phase 3
Waitlist Available
Research Sponsored by VistaGen Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial looks at how safe and tolerable it is to use PH94B, a drug for treating anxiety, up to 4 times per day for up to 12 months.

Eligible Conditions
  • Social Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse events and other safety measures
Liebowitz Social Anxiety Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: PH94B 3.2 microgramsExperimental Treatment1 Intervention
100 microliter nasal spray to each nostril up to four times a day as needed for acute anxiety
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PH94B
2014
Completed Phase 3
~70

Find a Location

Who is running the clinical trial?

VistaGen Therapeutics, Inc.Lead Sponsor
9 Previous Clinical Trials
1,102 Total Patients Enrolled
Jaakko Lappalainen, MD, PhDStudy DirectorVistaGen Therapeutics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Virginia
Washington
Other
New York
How old are they?
65+
18 - 65
What site did they apply to?
VistaGen Investigational Site
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
2021. "Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05030350.
~138 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top